{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:54:33Z","timestamp":1780458873749,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10741-022-10226-w","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T21:02:11Z","timestamp":1646427731000},"page":"1543-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?"],"prefix":"10.1007","volume":"27","author":[{"given":"Jean Michel","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maan","family":"Malahfji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aljizeeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-0484","authenticated-orcid":false,"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"10226_CR1","doi-asserted-by":"publisher","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2020) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization. J Nucl Cardiol 27(2):659\u2013673. https:\/\/doi.org\/10.1007\/s12350-019-01761-5. Accessed 25 Oct 2021","DOI":"10.1007\/s12350-019-01761-5"},{"key":"10226_CR2","doi-asserted-by":"publisher","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2019) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 26(6):2065\u20132123. https:\/\/doi.org\/10.1007\/s12350-019-01760-6. Accessed 25 Oct 2021","DOI":"10.1007\/s12350-019-01760-6"},{"key":"10226_CR3","doi-asserted-by":"publisher","unstructured":"Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111(2):186\u2013193. https:\/\/doi.org\/10.1161\/01.CIR.0000152819.97857.9D. Accessed 19 Oct 2021","DOI":"10.1161\/01.CIR.0000152819.97857.9D"},{"key":"10226_CR4","doi-asserted-by":"publisher","unstructured":"Kellman P, Arai AE, McVeigh ER, Aletras AH (2002) Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 47(2):372\u2013383. https:\/\/doi.org\/10.1002\/mrm.10051. Accessed 25 Oct 2021","DOI":"10.1002\/mrm.10051"},{"key":"10226_CR5","doi-asserted-by":"publisher","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132(16):1570\u20131579. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016567. Accessed 25 Oct 2021","DOI":"10.1161\/CIRCULATIONAHA.115.016567"},{"key":"10226_CR6","doi-asserted-by":"publisher","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51(10):1022\u20131030. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.049. Accessed 25 Oct 2021","DOI":"10.1016\/j.jacc.2007.10.049"},{"key":"10226_CR7","doi-asserted-by":"publisher","unstructured":"Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3(2):155\u2013164. https:\/\/doi.org\/10.1016\/j.jcmg.2009.09.023. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2009.09.023"},{"key":"10226_CR8","doi-asserted-by":"publisher","unstructured":"Ruberg FL, Appelbaum E, Davidoff R et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103(4):544\u2013549. https:\/\/doi.org\/10.1016\/j.amjcard.2008.09.105. Accessed 25 Oct 2021","DOI":"10.1016\/j.amjcard.2008.09.105"},{"key":"10226_CR9","doi-asserted-by":"publisher","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6(4):488\u2013497. https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.013. Accessed 19 Oct 2021","DOI":"10.1016\/j.jcmg.2012.11.013"},{"key":"10226_CR10","doi-asserted-by":"publisher","unstructured":"Austin BA, Tang WHW, Rodriguez ER et al (2009) Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2(12):1369\u20131377. https:\/\/doi.org\/10.1016\/j.jcmg.2009.08.008. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2009.08.008"},{"key":"10226_CR11","doi-asserted-by":"publisher","unstructured":"Takeda M, Amano Y, Tachi M, Tani H, Mizuno K, Kumita S (2013) MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease. Jpn J Radiol 31(10):693\u2013700. https:\/\/doi.org\/10.1007\/s11604-013-0238-0. Accessed 25 Oct 2021","DOI":"10.1007\/s11604-013-0238-0"},{"key":"10226_CR12","doi-asserted-by":"publisher","unstructured":"Deux J, Damy T, Rahmouni A, Mayer J, Plant\u00e9-Bordeneuve V (2014) Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study. Amyloid 21(4):246\u2013255. https:\/\/doi.org\/10.3109\/13506129.2014.956924. Accessed 25 Oct 2021","DOI":"10.3109\/13506129.2014.956924"},{"key":"10226_CR13","doi-asserted-by":"publisher","unstructured":"Zhao L, Tian Z, Fang Q (2016) Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovasc Disord 16:129. https:\/\/doi.org\/10.1186\/s12872-016-0311-6. Accessed 25 Oct 2021","DOI":"10.1186\/s12872-016-0311-6"},{"key":"10226_CR14","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A et al (2017) Magnetic resonance in transthyretin\u00a0cardiac amyloidosis. J Am Coll Cardiol 70(4):466\u2013477. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.053. Accessed 19 Oct 2021","DOI":"10.1016\/j.jacc.2017.05.053"},{"key":"10226_CR15","doi-asserted-by":"publisher","unstructured":"Dungu JN, Valencia O, Pinney JH et al (2014) CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 7(2):133\u2013142.https:\/\/doi.org\/10.1016\/j.jcmg.2013.08.015. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2013.08.015"},{"key":"10226_CR16","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A et al (2017) Magnetic resonance in transthyretin\u00a0cardiac amyloidosis. J Am Coll Cardiol 70(4):466\u2013477. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.053. Accessed 25 Oct 2021","DOI":"10.1016\/j.jacc.2017.05.053"},{"key":"10226_CR17","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Abdel-Gadir A, Treibel TA et al (2017) CMR-verified regression of cardiac AL amyloid after chemotherapy. JACC Cardiovasc Imaging 11(1):152\u2013154. https:\/\/doi.org\/10.1016\/j.jcmg.2017.02.012. Accessed 19 Oct 2021","DOI":"10.1016\/j.jcmg.2017.02.012"},{"key":"10226_CR18","doi-asserted-by":"publisher","unstructured":"White JA, Kim HW, Shah D et al (2014) CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging 7(2):143\u2013156. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3951756\/. https:\/\/doi.org\/10.1016\/j.jcmg.2013.09.019. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2013.09.019"},{"key":"10226_CR19","doi-asserted-by":"publisher","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157\u2013165. https:\/\/doi.org\/10.1016\/j.jcmg.2013.10.008. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2013.10.008"},{"issue":"1","key":"10226_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1532-429X-15-92","volume":"15","author":"JC Moon","year":"2013","unstructured":"Moon JC, Messroghli DR, Kellman P et al (2013) Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the european society of cardiology consensus statement. J Cardiovasc Magn Reson 15(1):92. https:\/\/doi.org\/10.1186\/1532-429X-15-92","journal-title":"J Cardiovasc Magn Reson"},{"key":"10226_CR21","doi-asserted-by":"publisher","unstructured":"Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis. Circulation: Cardiovascular Imaging. 6(1):34\u201339. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.978627. Accessed 19 Oct 2021","DOI":"10.1161\/CIRCIMAGING.112.978627"},{"key":"10226_CR22","doi-asserted-by":"publisher","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the european association for cardiovascular imaging (EACVI). J Cardiovasc Magn Reson 19(1):75. https:\/\/doi.org\/10.1186\/s12968-017-0389-8. Accessed 25 Oct 2021","DOI":"10.1186\/s12968-017-0389-8"},{"key":"10226_CR23","doi-asserted-by":"publisher","unstructured":"Mekinian A, Lions C, Leleu X et al (2010) Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. Am J Med 123(9):864\u2013868. https:\/\/doi.org\/10.1016\/j.amjmed.2010.03.022. Accessed 25 Oct 2021","DOI":"10.1016\/j.amjmed.2010.03.022"},{"key":"10226_CR24","doi-asserted-by":"publisher","unstructured":"Fontana M, Treibel TA, Martinez-Naharro A et al (2017) A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid. BMC Med Imaging 17(1):3. https:\/\/doi.org\/10.1186\/s12880-016-0173-5. Accessed 25 Oct 2021","DOI":"10.1186\/s12880-016-0173-5"},{"key":"10226_CR25","doi-asserted-by":"publisher","unstructured":"Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36(4):244\u2013251. https:\/\/doi.org\/10.1093\/eurheartj\/ehu444. Accessed 19 Oct 2021","DOI":"10.1093\/eurheartj\/ehu444"},{"key":"10226_CR26","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K et al (2019) Native T1 and extracellular volume in\u00a0Transthyretin amyloidosis. JACC Cardiovasc Imaging 12(5):810\u2013819. https:\/\/doi.org\/10.1016\/j.jcmg.2018.02.006. Accessed 19 Oct 2021","DOI":"10.1016\/j.jcmg.2018.02.006"},{"key":"10226_CR27","doi-asserted-by":"publisher","unstructured":"Raina S, Lensing SY, Nairooz RS et al (2016) Prognostic value of late\u00a0gadolinium\u00a0enhancement CMR in\u00a0systemic amyloidosis. JACC Cardiovasc Imaging 9(11):1267\u20131277. https:\/\/doi.org\/10.1016\/j.jcmg.2016.01.036. Accessed 25 Oct 2021","DOI":"10.1016\/j.jcmg.2016.01.036"},{"key":"10226_CR28","doi-asserted-by":"publisher","unstructured":"Bulluck H, White SK, Rosmini S et al (2015) T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson 17(1):73. https:\/\/doi.org\/10.1186\/s12968-015-0173-6","DOI":"10.1186\/s12968-015-0173-6"},{"key":"10226_CR29","doi-asserted-by":"publisher","unstructured":"Lurz P, Luecke C, Eitel I et al (2016) Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial. J Am Coll Cardiol 67(15):1800\u20131811. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.013. Accessed 5 Nov 2021","DOI":"10.1016\/j.jacc.2016.02.013"},{"key":"10226_CR30","doi-asserted-by":"publisher","unstructured":"Bohnen S, Radunski UK, Lund GK et al (2015) Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circulation: Cardiovas Imaging 8(6):e003073. https:\/\/doi.org\/10.1161\/circimaging.114.003073. Accessed 5 Nov 2021","DOI":"10.1161\/circimaging.114.003073"},{"key":"10226_CR31","doi-asserted-by":"publisher","unstructured":"Legou F, Tacher V, Damy T et al (2017) Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging. Diagn Interv Imaging 98(2):125\u2013132. https:\/\/doi.org\/10.1016\/j.diii.2016.08.007. Accessed 5 Nov 2021","DOI":"10.1016\/j.diii.2016.08.007"},{"key":"10226_CR32","doi-asserted-by":"publisher","unstructured":"Wassmuth R, Abdel-Aty H, Bohl S, Schulz-Menger J (2011) Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol 21(8):1643\u20131650. https:\/\/doi.org\/10.1007\/s00330-011-2109-3. Accessed 5 Nov 2021","DOI":"10.1007\/s00330-011-2109-3"},{"key":"10226_CR33","doi-asserted-by":"publisher","unstructured":"Kotecha T, Martinez-Naharro A, Treibel TA et al (2018) Myocardial edema and prognosis in\u00a0Amyloidosis. J Am Coll Cardiol 71(25):2919\u20132931. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.536. Accessed 5 Nov 2021","DOI":"10.1016\/j.jacc.2018.03.536"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-022-10226-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10226-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T07:35:16Z","timestamp":1660808116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-022-10226-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10226"],"URL":"https:\/\/doi.org\/10.1007\/s10741-022-10226-w","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"24 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research studies involving humans and\/or animals"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}